A Mind-Body Intervention for Chemotherapy-Induced Peripheral Neuropathy

Inclusion Criteria: * Diagnosed with cancer, stage 1-4. * Completed taxane- or platinum-based chemotherapy at least three months (90 days) ago but within 24 months of signing consent. Current use of anti-estrogen therapy, Herceptin, or PARP inhibitors is okay. * Experiencing at least grade 1 peripheral sensory neuropathy, peripheral motor neuropathy, or dysesthesias based on the National Cancer Institute Common Terminology Criteria for Adverse Events Version 4 (NCI CTCAE v4.0). * Age ≥ 18 years. * Concomitant use of analgesics is permitted if the dose has been stable for at least 2 weeks prior to study enrollment (no new analgesics have been added, discontinued, or changed in the 2 weeks prior to study enrollment). * Reasonable functional stability as assessed by the evaluating physician. * Must be able to understand and communicate proficiently in English. * Written informed consent obtained from subject and ability for subject to comply with the requirements of the study. Exclusion Criteria: * Syphilis, alcoholic neuropathy, diabetic neuropathy, neurological disorders, brain injury, or stroke, as assessed by the treating physician. * Medical history of neuropathy from any type of nerve compression (e.g., carpal tunnel or tarsal tunnel syndrome, radiculopathy, spinal stenosis, brachial plexopathy, leptomeningeal carcinomatosis), as assessed by the treating physician. * Neuropathy related to abnormal TSH or B12 levels as assessed by treating physician * Current severe depression, suicidal ideation, bipolar disease, alcohol abuse, or major eating disorder, as assessed by the treating physician. * Severe personality disorder or psychiatric disorder that would interfere with participation in a QiGong program, as assessed by the evaluating physician. * Currently participating in another QiGong or Tai Chi program.